![Rajeev Venkayya](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rajeev Venkayya
Direktor/Vorstandsmitglied bei
International AIDS Vaccine Initiative, Inc.
Profil
Dr. Rajeev Venkayya, MD, is a Director-Global Health Vaccine Delivery at Gates Foundation Trust and a President-Takeda Global Vaccine Business Unit at Takeda Pharmaceuticals International, Inc. He is on the Board of Directors at International AIDS Vaccine Initiative, Inc.
Dr. Venkayya was previously employed as a Chief Executive Officer & Director by Aerium Therapeutics, Inc., an Advisor by Centers for Disease Control & Prevention, an Independent Director by HilleVax, Inc., a Principal by The White House, and an Assistant Professor by University of California.
He received his graduate degree from Northeast Ohio Medical University.
Aktive Positionen von Rajeev Venkayya
| Unternehmen | Position | Beginn |
|---|---|---|
Gates Foundation Trust
 Gates Foundation Trust Financial ConglomeratesFinance Foundation | Corporate Officer/Principal | 27.10.2010 |
Takeda Pharmaceuticals International, Inc.
 Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Corporate Officer/Principal | - |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Rajeev Venkayya
| Unternehmen | Position | Ende |
|---|---|---|
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats | Vorstandsvorsitzender | 01.07.2024 |
| HILLEVAX, INC. | Direktor/Vorstandsmitglied | - |
Centers for Disease Control & Prevention
 Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center | Corporate Officer/Principal | - |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The White House
 The White House General GovernmentGovernment Government authority | Corporate Officer/Principal | - |
Ausbildung von Rajeev Venkayya
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Gates Foundation Trust
Gates Foundation Trust Financial ConglomeratesFinance Foundation | Finance |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops vaccines for AIDS | Health Technology |
Centers for Disease Control & Prevention
Centers for Disease Control & Prevention General GovernmentGovernment Operates as a government health center | Government |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting for pharmaceutical businesses | Commercial Services |
The White House
The White House General GovernmentGovernment Government authority | Government |
Northeast Ohio Medical University
 Northeast Ohio Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HilleVax, Inc.
 HilleVax, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in the development and commercialization of novel vaccine candidates | Health Technology |
Aerium Therapeutics, Inc.
Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in discovery & development of antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic & pandemic threats | Commercial Services |
